vcaonline.com
May 12, 2008
MOUNTAIN VIEW, Calif., May 12, 2008-- Revance Therapeutics, Inc. (“Revance”) today announced the completion of an additional $8 million investment to the Series C financing that was completed in December 2007. The financing included returning investors, Essex Woodlands...